Protomer Technologies
CA - PasadenaBiotechnology
Focus: Protomer Technologies is a biotechnology company focused on glucose-responsive insulin for metabolic diseases, founded in 2015 and based in Pasadena, CA. The company is publicly listed but has minimal disclosed operational data.
Profile data last refreshed 22h ago · AI intelligence enriched 3w ago
Funding Stage
PUBLIC
Open Jobs
0
About Protomer Technologies
AI assessmentNot HiringNo open roles listed right now. Follow Protomer Technologies to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Open Jobs (0)
No open positions listed yet. Check their careers page directly.
Interview Prep Quick Facts
Founded: 2015
Publications: 25 in PubMed
Help build intelligence for Protomer Technologies
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.